Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01444261 · ClinicalTrials.gov registry record · Phase 4
Prevention of Iron Deficiency in Breastfed Infants
A Phase 4 study of Anemia and Iron-deficiency, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 4
- Development phase
- 219
- Enrollment target
- 1
- Study location
NCT01444261 is a Phase 4 study of Anemia and Iron-deficiency that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 219 participants, below the 425-participant average among 72 other Anemia trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01444261, a Phase 4 study of Anemia and Iron-deficiency, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 219 participants
- Enrollment target
- 1
- Study location
Study Summary
With early screening and appropriate iron supplementation, iron deficiency in the first year of life can be prevented in breastfed infants.
Conditions Studied
Interventions
- OTHER control
- DIETARY_SUPPLEMENT Fer-in-Sol
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-04 |
| Phase | Phase 4 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01444261
The ClinicalTrials.gov registry entry for NCT01444261 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 425-participant average among 72 other Anemia trials with a reported enrollment target (48% lower). The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which control is the first listed.
NCT01444261 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT01444261 about?
NCT01444261 is a clinical study titled "Prevention of Iron Deficiency in Breastfed Infants". With early screening and appropriate iron supplementation, iron deficiency in the first year of life can be prevented in breastfed infants.
What is the current status of trial NCT01444261?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 219 participants. The study started on 2010-12. Estimated completion is 2014-04.
What conditions does trial NCT01444261 study?
This clinical trial studies the following conditions: Anemia, Iron-deficiency.
What interventions are being tested in trial NCT01444261?
The interventions under investigation include: control (OTHER), Fer-in-Sol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01444261?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01444261 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Iron Deficiency Anemia (IDA) and the Brain
RECRUITING · Phase 4
-
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETED · Phase 4
-
Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients
COMPLETED · Phase 4
-
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
COMPLETED · Phase 4
-
IV Iron Safety: Evaluation of Iron Species in Healthy Subjects
COMPLETED · Phase 4
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.